R-146225

N/A

Report date: 2024/12/05 16:47:21

NME

Base Information

Drug NameR-146225

Drug Alias NameR-146225

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInterleukin-5 inhibitors

TargetsInterleukin-5

Therapy Area/IndicationsHypersensitivity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJohnson & Johnson

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesJohnson & Johnson

Active IndicationsN/A

Inactive IndicationsHypersensitivity

ATC CodeN/A